OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
Study sponsor: Anavex Life Sciences Corp. · AVXL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-06-14Actual
Enrollment · participants300Actual
Source updated2024-08-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.